Advertisement

European Radiology

, Volume 27, Issue 11, pp 4699–4709 | Cite as

Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy

  • Gang Zheng
  • Hanzhang Lu
  • Wenkui Yu
  • Song Luo
  • Ya Liu
  • Wei Liu
  • Hui Liu
  • Long Wu
  • Lijuan Zheng
  • Xiang Kong
  • Long Jiang ZhangEmail author
  • Guang Ming Lu
Head and Neck

Abstract

Objectives

To assess how the severity of hepatic encephalopathy (HE) affects perfusion and metabolic changes in cirrhotic patients and the association between severity and liver disease and anemia.

Methods

The study groups comprised 31 healthy subjects and 33 cirrhotic patients who underwent MR examinations, and blood and neuropsychological tests. Of the cirrhotic patients, 14 were unaffected, and 11 had covert HE (CHE) and 8 overt HE (OHE). Global cerebral blood flow (CBF), oxygen extraction fraction (OEF), and metabolic rate of oxygen (CMRO2) were noninvasively measured by phase-contrast and T2-relaxation-under-spin-tagging MRI. Correlations were performed between MR measurements, hematocrits, ammonia levels, Child-Pugh scores and neuropsychological test scores.

Results

Compared with the values in healthy subjects, CBF was higher in unaffected patients, the same in CHE patients and lower in OHE patients, OEF was higher in all patients, and CMRO2 was the same in unaffected and CHE patients and lower in OHE patients. Hematocrit was negatively correlated with CBF and OEF, but not with CMRO2. Ammonia level was negatively correlated with CBF and CMRO2, and Child-Pugh score was negatively correlated with CMRO2.

Conclusions

The severity-associated alterations in cirrhotic patients indicate that homeostasis of oxygen delivery and oxidative metabolism in HE is regulated by multiple mechanisms. These physiological alterations appeared to be associated with the degree of anemia, ammonia level, and liver function.

Key Points

CBF, OEF and CMRO2 did not change monotonically with HE progression.

Anemia possibly contributed to CBF and OEF changes in cirrhotic patients.

Liver dysfunction mainly contributed to changes in CMRO2 in cirrhotic patients.

Keywords

Hepatic encephalopathy Cirrhosis Cerebral blood flow Oxygen extraction fraction Cerebral metabolic rate of oxygen 

Abbreviations

CBF

Cerebral blood flow

CHE

Covert hepatic encephalopathy

CMRO2

Cerebral metabolic rate of oxygen

HE

Hepatic encephalopathy

MMSE

Mini mental state examination

OEF

Oxygen extraction fraction

OHE

Overt hepatic encephalopathy

pcMRI

Phase-contrast MRI

PHES

Psychometric hepatic encephalopathy score

TRUST

T2-relaxation-under-spin-tagging

Notes

Compliance with ethical standards

Guarantor

The scientific guarantor of this publication is Long Jiang Zhang.

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Funding

This study received funding from the National Natural Science Foundation of China (grants 81671667, 81471644 and 81101039 to G.Z. and grants 81322020, 81230032 and 81171313 to L.J.Z.), and the China Postdoctoral Science Foundation (grant 2016T90445, 2014T71014 and 2015M570436 to G.Z.).

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was obtained from all subjects in this study.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• Prospective

• Cross sectional study

• Performed at one institution

References

  1. 1.
    Vilstrup H, Amodio P, Bajaj J et al (2014) Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60:715–735CrossRefGoogle Scholar
  2. 2.
    Lockwood AH, Yap EW, Rhoades HM, Wong WH (1991) Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab 11:331–336CrossRefGoogle Scholar
  3. 3.
    Ahl B, Weissenborn K, van den Hoff J et al (2004) Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73–79CrossRefGoogle Scholar
  4. 4.
    Iversen P, Sørensen M, Bak LK et al (2009) Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy. Gastroenterology 136:863–871CrossRefGoogle Scholar
  5. 5.
    Gjedde A, Keiding S, Vilstrup H, Iversen P (2010) No oxygen delivery limitation in hepatic encephalopathy. Metab Brain Dis 25:57–63CrossRefGoogle Scholar
  6. 6.
    Dam G, Keiding S, Munk OL et al (2013) Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake. Hepatology 57:258–265CrossRefGoogle Scholar
  7. 7.
    O'Carroll RE, Hayes PC, Ebmeier KP et al (1991) Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet 337:1250–1253CrossRefGoogle Scholar
  8. 8.
    Catafau AM, Kulisevsky J, Bernà L et al (2000) Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy. J Nucl Med 41:405–410PubMedGoogle Scholar
  9. 9.
    Yazgan Y, Narin Y, Demirturk L et al (2003) Value of regional cerebral blood flow in the evaluation of chronic liver disease and subclinical hepatic encephalopathy. J Gastroenterol Hepatol 18:1162–1167CrossRefGoogle Scholar
  10. 10.
    Nakagawa Y, Matsumura K, Iwasa M, Kaito M, Adachi Y, Takeda K (2004) Single photon emission computed tomography and statistical parametric mapping analysis in cirrhotic patients with and without minimal hepatic encephalopathy. Ann Nucl Med 18:123–129CrossRefGoogle Scholar
  11. 11.
    Iwasa M, Matsumura K, Nakagawa Y et al (2005) Evaluation of cingulate gyrus blood flow in patients with liver cirrhosis. Metab Brain Dis 20:7–17CrossRefGoogle Scholar
  12. 12.
    Zheng G, Zhang LJ, Cao Y, Lu GM (2013) Venous blood ammonia can be associated with cerebral blood flow in hepatic encephalopathy. Hepatology 58:832–833CrossRefGoogle Scholar
  13. 13.
    Zheng G, Zhang LJ, Cao Y et al (2013) Transjugular intrahepatic portosystemic shunt induced short- and long-term cerebral blood flow variations in cirrhotic patients: an arterial spin labeling MRI study. Metab Brain Dis 28:463–471CrossRefGoogle Scholar
  14. 14.
    Felipo V, Urios A, Giménez-Garzó C et al (2014) Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests. World J Gastroenterol 20:11815–11825CrossRefGoogle Scholar
  15. 15.
    Zheng G, Zhang LJ, Zhong J et al (2013) Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis. Eur J Radiol 82:1981–1988CrossRefGoogle Scholar
  16. 16.
    Testa R, Rodriguez G, Arvigo F et al (1989) Cerebral blood flow and plasma free tryptophan in cirrhotics with and without hepatic encephalopathy. Ital J Neurol Sci 10:415–421CrossRefGoogle Scholar
  17. 17.
    Macías-Rodríguez RU, Duarte-Rojo A, Cantú-Brito C et al (2015) Cerebral haemodynamics in cirrhotic patients with hepatic encephalopathy. Liver Int 35:344–352CrossRefGoogle Scholar
  18. 18.
    Ikeda K, Tsuji H, Azuma K et al (2001) Alteration of regional cerebral metabolism in patients with cirrhosis in positron emission tomography. Fukuoka Igaku Zasshi 92:306–314PubMedGoogle Scholar
  19. 19.
    Xu F, Ge Y, Lu H (2009) Noninvasive quantification of whole-brain cerebral metabolic rate of oxygen (CMRO2) by MRI. Magn Reson Med 62:141–148CrossRefGoogle Scholar
  20. 20.
    Lu H, Ge Y (2008) Quantitative evaluation of oxygenation in venous vessels using T2-relaxation-under-spin-tagging MRI. Magn Reson Med 60:357–363CrossRefGoogle Scholar
  21. 21.
    Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy – definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716–721CrossRefGoogle Scholar
  22. 22.
    Córdoba J, Mínguez B (2008) Hepatic encephalopathy. Semin Liver Dis 28:70–80CrossRefGoogle Scholar
  23. 23.
    Duarte-Rojo A, Estradas J, Hernández-Ramos R, Ponce-de-León S, Córdoba J, Torre A (2011) Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy. Dig Dis Sci 56:3014–3023CrossRefGoogle Scholar
  24. 24.
    Zheng G, Wen J, Lu H et al (2016) Elevated global cerebral blood flow, oxygen extraction fraction and unchanged metabolic rate of oxygen in young adults with end-stage renal disease: an MRI study. Eur Radiol 26:1732–1741CrossRefGoogle Scholar
  25. 25.
    Haccke EM, Brown RW, Thompson MR, Venkatesan R (1999) MR angiography and flow quantification. magnetic resonance imaging: physical principles and sequence design. Wiley-Liss, New YorkGoogle Scholar
  26. 26.
    Sheng M, Lu H, Liu P, Thomas BP, McAdams CJ (2015) Cerebral perfusion differences in women currently with and recovered from anorexia nervosa. Psychiatry Res 232:175–183CrossRefGoogle Scholar
  27. 27.
    Jordan LC, Gindville MC, Scott AO et al (2016) Non-invasive imaging of oxygen extraction fraction in adults with sickle cell anaemia. Brain 139:738–750CrossRefGoogle Scholar
  28. 28.
    Hayashi T, Watabe H, Kudomi N et al (2003) A theoretical model of oxygen delivery and metabolism for physiologic interpretation of quantitative cerebral blood flow and metabolic rate of oxygen. J Cereb Blood Flow Metab 23:1314–1323CrossRefGoogle Scholar
  29. 29.
    Hayashi T, Kudomi N, Teramoto N et al (2004) A physiological model for cerebral oxygen delivery and consumption and effective oxygen diffusibility evaluated by PET. Int Congr Ser 1265:228–237CrossRefGoogle Scholar
  30. 30.
    Gjedde A, Johannsen P, Cold GE, Ostergaard L (2005) Cerebral metabolic response to low blood flow: possible role of cytochrome oxidase inhibition. J Cereb Blood Flow Metab 25:1183–1196CrossRefGoogle Scholar
  31. 31.
    Guevara M, Bru C, Ginès P et al (1998) Increased cerebrovascular resistance in cirrhotic patients with ascites. Hepatology 28:39–44CrossRefGoogle Scholar
  32. 32.
    Ginès P, Kamath PS, Arroyo V (2011) Chronic liver failure: mechanisms and management. Humana Press, TotowaCrossRefGoogle Scholar
  33. 33.
    Tarantino G, Citro V, Esposito P et al (2009) Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. BMC Gastroenterol 9:21CrossRefGoogle Scholar

Copyright information

© European Society of Radiology 2017

Authors and Affiliations

  • Gang Zheng
    • 1
    • 2
  • Hanzhang Lu
    • 3
  • Wenkui Yu
    • 4
  • Song Luo
    • 1
  • Ya Liu
    • 1
    • 2
  • Wei Liu
    • 5
  • Hui Liu
    • 6
  • Long Wu
    • 1
  • Lijuan Zheng
    • 1
  • Xiang Kong
    • 1
  • Long Jiang Zhang
    • 1
    Email author
  • Guang Ming Lu
    • 1
  1. 1.Department of Medical Imaging, Jinling HospitalMedical School of Nanjing UniversityNanjingChina
  2. 2.College of Civil AviationNanjing University of Aeronautics and AstronauticsNanjingChina
  3. 3.The Russell H. Morgan Department of Radiology & Radiological ScienceJohns Hopkins UniversityBaltimoreUSA
  4. 4.Institute of General Surgery, Jinling HospitalMedical School of Nanjing UniversityNanjingChina
  5. 5.Siemens Shenzhen Magnetic Resonance Ltd.ShenzhenChina
  6. 6.Siemens MR NEA Collaboration, Siemens Ltd., ChinaShanghaiChina

Personalised recommendations